This editorial refers to 'Long-term mortality in patients with atrial septal defect: a nationwide cohort-study' † , by C. Nyboe et al., on page 993.
the simplest kind of ASD, can have quite different locations within the atrial septum, with variable relationships to the SVC, IVC, aortic root, coronary sinus, and/or the atrioventricular (AV) valves. Such ASDs can have flimsy or firm tissue margins and can be single or multiple.
The next most common type of ASD is the primum defect, in 15% of ASD cases. This is a much more complicated defect which is positioned inferiorly in the atrial septum and involves the endocardial cushion. Primum ASDs are associated with extreme left axis deviation on the surface ECG rather than the right axis deviation that is common in other ASD types, and it is invariably associated with some degree of morphological abnormality of the left AV valve (which is not a true mitral valve, but is the left side of a common AV valve apparatus with an apparent medial 'cleft', which can sometimes be quite large).
The third most common type of ASD is a superiorly located type 'sinus venosus' type ASD, accounting for 5-10% of ASD cases. This lesion is almost invariably associated with anomalous drainage of some of the right-sided pulmonary veins, usually the upper and/or middle lobe veins, which drain to the SVC-right atrial junction rather than to the left atrium. This exacerbates the degree of left to right shunting by 'pink' blood from these pulmonary veins returning directly to the right side of the heart, in addition to the shunting through the ASD.
These latter two types of ASD are never amenable to percutaneous device closure and require surgical repair, where indicated, by an experienced Congenital Heart Surgeon. Primum ASD closure often requires repair of the left-sided AV valve, and sinus venosus ASD closure almost always requires intracardiac rerouting of the anomalous right-sided pulmonary veins to the left atrium.
In addition to these anatomical variants, the size of the ASD and the relative compliances of the left and right ventricles determine the degree of left to right shunting. In the presence of large defects, increases in pulmonary flow can lead to increases in pulmonary vascular resistance (PVR) which can eventually alter the magnitude and/ or direction of shunting through the defect. In extreme cases of elevated PVR, shunt reversal can occur through the ASD (Eisenmenger syndrome) and this leads to cyanosis, erythrocytosis, hyperviscosity, and the sequelae of those changes. 2 Pulmonary vascular disease more commonly complicates sinus venosus ASDs than secundum ASDs. 3 For these reasons, of considerable anatomical and physiological heterogeneity, the concept of ASDs being a 'simple' congenital heart lesion is deceptive, although ASD is truly simpler than many other congenital heart defects. In this context, in this issue of the journal, Nyboe et al. 4 remind us of the potential adverse consequences of ASD by publishing the results of a nationwide cohort study of ASD patients from Denmark, showing higher long-term mortality in ASD patients compared with a sex-and birth year-matched general population cohort. They suggest the possibility of excess mortality even in young patients with ASD closure, and even more so in patients in whom the ASD has not been closed.
There are considerable strengths to the current study. Denmark has a National Patient Registry (established since 1977) with a unique Potential limitations should, however, be noted. Case finding was probably less complete prior to the establishment of the National Patient Register in 1977. Some patients with small ASDs may not be diagnosed at all until later life and so would not have been included in this analysis. Probably the most important limitation is the inability to distinguish between secundum, primum, and sinus venosus type ASDs. For the anatomical reasons outlined above, the complexities of treatment and attendant risks of morbidity and mortality are clearly likely to be higher in the primum and sinus venosus subgroups and such analyses of outcomes by defect type cannot be deduced from the analysis as presented. 'Unclosed' ASDs in this analysis could have included those ASDs that were too small to be problematic, with probably very benign outcomes, and those which were not closed as they had already caused shunt reversal and Eisenmenger syndrome, obviously with poorer outcomes. 5 One final caveat in interpretation is important and that regards the authors' conclusion that survival of ASD patients with closure at age <18 years is less good than a matched general population. Their figure 3 actually shows almost overlapping survival curves up to age 40 years. Confidence in good survival outcomes in patients with ASDs closed early in life is also provided by the seminal experience of Murphy et al. from the Mayo Clinic, published in 1990. 6 Despite these limitations, the data from Nyboe et al. 4 strengthen the view that patients with ASD should almost never be regarded as 'cured' and require careful attention. From first principles, this should hardly surprise us. If an ASD has been closed, there is still scarring on the right atrium (the septum and/or the free wall), which is a potential focus for later arrhythmia, or a foreign body on the atrial septum (in cases of device closure). As such defects are only closed if there is right heart dilatation, 7 in PVR that existed prior to closure) could have adverse long-term consequences. If the defect has not been closed because it is too small to have resulted in any right heart chamber dilatation, the outcome is likely to be very good (and this is not precluded by the observations of Nyboe et al.) . It should be noted, however, that with age-or disease-related stiffening of the left ventricle, the degree of left to right shunting through an ASD might increase over time and thence lead to later life right heart dilatation; so closure may indeed be indicated later in life. 8 Therefore, even this group requires ongoing surveillance, abeit probably on an infrequent basis only. If a defect has been left open because it has resulted in very high PVR, then clearly this group would be expected to have premature mortality 5 and they need careful supportive care and occasionally consideration of selective pulmonary vasodilator treatment(s) and even heart/lung transplantation. Fortunately, pulmonary vasodilator drugs may be of therapeutic benefit in patients with ASD and markedly elevated PVR, 9 although mortality benefits from such treatments have not been demonstrated in this situation.
As will be apparent from the preceding discussion, decisions about which patients should have ASD closure, by what technique, and regarding the duration and nature of follow-up are not straightforward. In all but the simplest defects, evaluation by Specialist Congenital Heart Cardiologists is important, to provide optimal care. Although many children and adults with congenital heart disease can lead long and productive lives, expert care is required to facilitate accurate diagnosis, appropriate treatment decisions, and, often, ongoing surveillance. Nyboe et al. have provided a timely reminder of the complexities that can arise in even the 'simplest' of congenital heart diseases, such as ASD.
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